{"schema_version":"secwatch.filing_event.v1","accession":"0001517022-23-000044","form_type":"8-K","ticker":"AKBA","cik":"0001517022","company_name":"Akebia Therapeutics, Inc.","filed_at":"2023-11-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.336635+00:00","generated_at":"2026-06-07T22:38:35.983223+00:00","sec_items":["8.01"],"event_type":"litigation","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Akebia settles all patent disputes with FibroGen and Astellas in EU, UK, Japan","bullets":["Settlement covers European (UK) Patent Nos. 2289531, 1463823, 2322155, 1633333, 2322153, 2298301 and Japanese Patent Nos. 4845728, 5474741, 5474872.","Resolves FibroGen's opposition to Akebia's European Patent No. 3357911 before the European Patent Office.","All ongoing litigation in UK courts and Japan Intellectual Property High Court to be terminated under agreement.","No financial terms or other business impact disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001517022-23-000044","json":"https://secwatch.observer/filing/0001517022-23-000044.json","markdown":"https://secwatch.observer/filing/0001517022-23-000044.md","text":"https://secwatch.observer/filing/0001517022-23-000044.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1517022/000151702223000044/0001517022-23-000044-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1517022/000151702223000044/akba-20231121.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T22:38:35.983223+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}